Simulations Plus (NASDAQ:SLP) Releases Earnings Results

Simulations Plus (NASDAQ:SLP) announced its quarterly earnings results on Tuesday. The technology company reported $0.19 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.04, Briefing.com reports. The company had revenue of $18.54 million during the quarter, compared to analysts’ expectations of $17.92 million. Simulations Plus had a return on equity of 7.80% and a net margin of 14.36%. Simulations Plus’s revenue was up 14.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.20 EPS. Simulations Plus updated its FY24 guidance to $0.54-0.56 EPS and its FY 2024 guidance to 0.540-0.560 EPS.

Simulations Plus Stock Performance

Shares of NASDAQ:SLP opened at $39.89 on Thursday. The firm has a market cap of $797.40 million, a P/E ratio of 75.26 and a beta of 0.72. Simulations Plus has a 52-week low of $32.69 and a 52-week high of $52.69. The business’s 50 day simple moving average is $47.68 and its two-hundred day simple moving average is $44.15.

Simulations Plus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 5th. Stockholders of record on Monday, July 29th will be issued a dividend of $0.06 per share. The ex-dividend date of this dividend is Monday, July 29th. This represents a $0.24 annualized dividend and a dividend yield of 0.60%. Simulations Plus’s dividend payout ratio is currently 45.28%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on SLP shares. Craig Hallum reiterated a “buy” rating and set a $56.00 target price on shares of Simulations Plus in a research report on Wednesday. William Blair initiated coverage on shares of Simulations Plus in a research note on Friday, June 28th. They issued an “outperform” rating on the stock. Finally, Oppenheimer raised their target price on Simulations Plus from $55.00 to $65.00 and gave the stock an “outperform” rating in a research report on Thursday, June 13th.

Insider Activity at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of $45.95, for a total value of $919,000.00. Following the transaction, the director now directly owns 3,580,857 shares of the company’s stock, valued at $164,540,379.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Simulations Plus news, Director Daniel L. Weiner sold 3,250 shares of the firm’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $48.31, for a total transaction of $157,007.50. Following the transaction, the director now directly owns 8,759 shares in the company, valued at approximately $423,147.29. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction on Wednesday, May 1st. The stock was sold at an average price of $45.95, for a total transaction of $919,000.00. Following the transaction, the director now directly owns 3,580,857 shares in the company, valued at $164,540,379.15. The disclosure for this sale can be found here. In the last 90 days, insiders sold 44,500 shares of company stock valued at $2,072,198. 20.90% of the stock is owned by company insiders.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.